
Eisai Investor Relations Material
Latest events

Q3 2025
Eisai
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Eisai Co Ltd
Access all reports
Eisai Co., Ltd. is a global pharmaceutical company based in Tokyo, Japan. The company focuses on the research and development, manufacturing, and marketing of prescription medicines. Eisai's business activities extend to the discovery, development, manufacture, and sale of pharmaceuticals, including a broad range of therapeutic areas such as neurology and oncology. Eisai is headquartered in Bunkyo-ku, Tokyo, Japan, and its shares are listed on the Tokyo Stock Exchange.
Key slides for Eisai Co Ltd


Q1 2025
Eisai Co Ltd


Q3 2025
Eisai Co Ltd
Latest articles
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
)
Ramon Laguarta: PepsiCo's Veteran Chairman and CEO
Ramon Laguarta, CEO and Chairman of the food and beverage giant PepsiCo leads its global expansion and transition toward a more sustainable future.
10 Mar 2025
)
Rise of the Clog: The Unexpected Success of Crocs
Crocs has created a unique position in the shoe market with an eye-catching design and marketing strategy involving several successful collaborations.
7 Mar 2025
Ticker symbol
4523
Country
🇯🇵 Japan